Department of Dermatology and Allergy, Allergy-Centre-Charité, Charité - University Hospital Berlin, Berlin, Germany.
Allergy. 2014 Jul;69(7):e1-29. doi: 10.1111/all.12370.
This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin. It is a joint initiative of the Dermatology Section of the European Academy of Allergy and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA(2) LEN), the European Dermatology Forum (EDF), and the World Allergy Organization (WAO) with the participation of delegates of 21 national and international societies. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS) and is published in Allergy 2014; 69:868-887.
本方法报告详细描述了指南制定的过程。它是使用“推荐评估、制定和评估分级”(GRADE)方法进行系统文献回顾以及 2012 年 11 月 28 日至 29 日在柏林举行的结构化共识会议的结果。这是欧洲过敏与临床免疫学学会(EAACI)皮肤科分会、欧盟资助的卓越网络、全球过敏与哮喘欧洲网络(GA[2]LEN)、欧洲皮肤病学会(EDF)和世界过敏组织(WAO)的联合倡议,有 21 个国家和国际学会的代表参加。本指南涵盖了荨麻疹的定义和分类,同时考虑到了确定其病因、诱发因素和发病机制方面的最新进展。此外,它还概述了不同类型荨麻疹的基于证据的诊断和治疗方法。该指南得到了欧洲医学专家联盟(UEMS)的认可和接受,并发表在《过敏》2014 年第 69 卷:868-887 页。